|
Besluiten ZRIG - t.b.v. 2026 e.v. |
|
|
|
|
|
|
ZRIG - Antibiotica 2026 e.v. |
|
|
|
|
Pakket |
Leverancier |
Looptijd in maanden |
Opmerkingen |
|
Aciclovir (poeder) |
Hikma Pharma Benelux B.v. |
36 |
|
|
Amoxicilline |
Prolepha Research Bv |
36 |
|
|
Anidulafungine |
Pfizer Bv |
12 |
|
|
Ceftriaxon |
Hikma Pharma Benelux B.v. |
36 |
|
|
Ciprofloxacine (IV) |
Fresenius Kabi Nederland Bv |
24 |
|
|
Ciprofloxacine (Oraal) |
Aurobindo Pharma Bv |
36 |
|
|
Clindamycine |
Grindeks Kalceks Nederland B.v. |
36 |
|
|
Flucloxacilline |
Fresenius Kabi Nederland Bv |
12 |
|
|
Fluconazol |
Fresenius Kabi Nederland Bv |
24 |
|
|
Levofloxacine |
Fresenius Kabi Nederland Bv |
24 |
|
|
Meropenem |
Grindeks Kalceks Nederland B.v. |
12 |
|
|
Mitomycine |
Pharmanovia Benelux Bv |
12 |
|
|
Piperacilline Met Betalactamaseremmer |
Grindeks Kalceks Nederland B.v. |
12 |
|
|
Valaciclovir |
Aurobindo Pharma Bv |
36 |
|
|
Vancomycine |
Hikma Pharma Benelux B.v. |
36 |
|
|
|
|
|
|
|
ZRIG - Biologicals 2026 e.v. |
|
|
|
|
Pakket |
Leverancier |
Looptijd in maanden |
Opmerkingen |
|
Bevacizumab |
Biocon Biologics Belgium Bv |
36 |
|
|
Filgrastim |
Accord Healthcare B.v. |
24 |
|
|
Infliximab IV (Biosimilar) |
Sandoz Bv |
36 |
|
|
Infliximab IV (Specialite) |
Janssen-Cilag Bv |
12 |
Niet-exclusief |
|
Trastuzumab IV |
Accord Healthcare B.v. |
24 |
|
|
Trastuzumab SC |
Roche Nederland Bv |
12 |
|
|
|
|
|
|
|
ZRIG - Contrastmiddelen 2026 e.v. |
|
|
|
|
Pakket |
Leverancier |
Looptijd in maanden |
Opmerkingen |
|
Gadoteerzuur |
Ge Healthcare Bv |
36 |
|
|
Jodixanol |
Ge Healthcare Bv |
36 |
Niet-exlusief |
|
Johexol |
Ge Healthcare Bv |
36 |
Niet-exlusief |
|
|
|
|
|
|
ZRIG - Immunoglobulines 2026 e.v. |
|
|
|
|
Pakket |
Leverancier |
Looptijd in maanden |
Opmerkingen |
|
Privigen |
CSL Behring |
36 |
Primaire leverancier |
|
Nanogam |
Prothya Biosolutions Netherlands BV |
36 |
Secundaire leverancier |
|
Kiovig |
Takeda Nederland Bv |
36 |
Secundaire leverancier |
|
Gammagard S/D |
Takeda Nederland Bv |
36 |
Secundaire leverancier |
|
|
|
|
|
|
ZRIG - Natalizumab 2026 e.v. |
|
|
|
|
Pakket |
Leverancier |
Looptijd in maanden |
Opmerkingen |
|
Natalizumab |
Biogen |
24 |
|
|
|
|
|
|
|
ZRIG - Oncolytica 2026 e.v. |
|
|
|
|
Pakket |
Leverancier |
Looptijd in maanden |
Opmerkingen |
|
Abirateron |
Vivanta Generics S.r.o. |
24 |
|
|
Anagrelide |
Glenmark Pharmaceuticals B.v. |
24 |
|
|
Bortezomib |
Accord Healthcare B.v. |
24 |
|
|
Cisplatine |
Accord Healthcare B.v. |
24 |
|
|
Dasatinib |
Vivanta Generics S.r.o. |
24 |
|
|
Docetaxel |
Accord Healthcare B.v. |
24 |
|
|
Etoposide (Oraal) |
Eurocept International Bv |
12 |
|
|
Etoposide IV |
Accord Healthcare B.v. |
24 |
|
|
Everolimus |
Sandoz Bv |
12 |
|
|
Gemcitabine |
Aurobindo Pharma Bv |
36 |
|
|
Pomalidomide |
Sandoz Bv |
24 |
|
|
Sunitinib |
Accord Healthcare B.v. |
24 |
|
|
Trastuzumab Emtansine |
Roche Nederland Bv |
12 |
|
|
|
|
|
|
|
ZRIG - Sevofluraan 2026 e.v. |
|
|
|
|
Pakket |
Leverancier |
Looptijd in maanden |
Opmerkingen |
|
Sevofluraan |
Baxter B.V. |
36 |
|
|
|
|
|
|
|
ZRIG - 2026 e.v. |
|
|
|
|
Pakket |
Leverancier |
Looptijd in maanden |
Opmerkingen |
|
Amiodaron |
Hameln Pharma Gmbh |
36 |
|
|
Aprepitant |
Aurobindo Pharma Bv |
36 |
|
|
Atropine wwsp |
Accord Healthcare B.v. |
24 |
niet-exclusief |
|
Bosutinib |
Centrafarm Bv |
24 |
|
|
Clopidogrel |
Aurobindo Pharma Bv |
36 |
|
|
Clozapine |
Aurobindo Pharma Bv |
36 |
|
|
Dalteparine |
Pfizer bv |
24 |
Geldig voor dalteparine instellingen |
|
Epoetine Alfa |
Sandoz bv |
24 |
|
|
Epoetine Beta |
Roche Nederland Bv |
12 |
|
|
Fenytoine |
Aurobindo Pharma Bv |
12 |
|
|
Flumazenil |
Hameln Pharma Gmbh |
36 |
|
|
Fluoresceine |
Fresenius Kabi Nederland Bv |
24 |
|
|
Folinezuur |
Grindeks Kalceks Nederland B.v. |
36 |
|
|
Fulvestrant |
Xiromed |
36 |
|
|
Gelatine |
Fresenius Kabi Nederland Bv |
24 |
|
|
Granisetron IV |
Fresenius Kabi Nederland Bv |
24 |
|
|
Indigokarmijn |
Pharmanovia Benelux bv |
36 |
|
|
Ipratropium |
Boehringer Ingelheim Bv |
12 |
|
|
Levetiracetam IV & zak |
Eureco Pharma |
36 |
Leden kunnen beide preparaten inzetten |
|
Levetiracetam oraal |
Aurobindo Pharma Bv |
36 |
|
|
Macrogol |
Norgine Pharma B.v. & Otc Medical Bv |
12 |
|
|
Metformine |
Aurobindo Pharma Bv |
36 |
|
|
Methoxypeg-Epo Beta |
Roche Nederland Bv |
12 |
|
|
Milrinon |
Devrimed B.V |
24 |
|
|
Naloxon |
Hameln Pharma Gmbh |
36 |
|
|
Pantoprazol IV |
Sun Pharmaceutical Industries Europe Bv |
24 |
|
|
Pantoprazol oraal |
Aurobindo Pharma Bv |
36 |
|
|
Paracetamol IV |
B.braun Medical Bv |
24 |
|
|
Paracetamol oraal |
Aurobindo Pharma Bv |
36 |
|
|
Ferricarboxymaltose |
Viatris |
24 |
|
|
Quetiapine |
Aurobindo Pharma Bv |
36 |
|
|
Tamsulosine |
Aurobindo Pharma Bv |
36 |
|
|
Tenecteplase |
Boehringer Ingelheim Bv |
12 |
|
|
|
|
|
|
|
|
|
|
|
|
Overig |
Leverancier |
Overeenkomst tot |
|
|
Omalizumab |
Celltrion |
Eind 2026 |
|
|
Axitinib |
Accord Healthcare B.v. |
Eind 2026 |
|
|
|
|
|
|
|
Niet gecontracteerd |
Opmerkingen |
|
|
|
Ciprofloxacine 250mg |
Geen geschikte verpakking aangeboden |
|
|
Apremilast |
Volgt januari 2026 |
|
|
|
Calcium |
Uit pakket |
|
|
|
Calcium & vitamine D |
Uit pakket |
|
|
|
Salbutamol Met Ipratropiumbromide |
Uit pakket |
|
|